19 August 2013 | News | By BioSpectrum Bureau
Marken's depot in Singapore will assemble and store kits and distribute all clinical materials to investigator sites throughout Asia
Singapore: Marken has launched a depot in Singapore to receive drug product and kit materials to assemble and store kits and distribute all clinical materials to investigator sites throughout Asia.
Marken had recently been granted a 12-year license to ship biological samples and drug product within China and also opened an office in Seoul. South Korea, to manage customer service operations and offer local service to its customers, who currently operate in the country.
The kit-building unit in Singapore is managed by a dedicated trained staff and is supported by the GMP operators and QA personnel who operate the depot facility. The depot is located adjacent to Marken's Singapore distribution hub, located near the Changi airport, Singapore.
Marken currently produces 15,000 kits per month and distributes more than 350,000 kits annually to investigator sites around the world. Ample capacity is currently available, and more capacity will be added as client demand develops.
Mr Wes Wheeler, CEO, Marken said that, "We are pleased to be able to offer this expanded service to our clients in the APAC region. Our ability to assemble kits in Singapore gives us a solid platform in Asia and again enhances our portfolio of services to clients in the region. We look forward to serving more global clients with our other facilities as we continue to grow, both in the Asia region and around the world."